Related Experiment Video
Updated: Jan 31, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in Drosophila Models of Myotonic Dystrophy Type 1
Anissa Souidi1, Monika Zmojdzian2, Krzysztof Jagla3
1GReD, INSERM U1103, CNRS, UMR6293, University of Clermont Auvergne, 28 Place Henri Dunant, 63000 Clermont-Ferrand, France. anissa.souidi@uca.fr.
Abstract:
Myotonic dystrophy type 1 (DM1), the most common cause of adult-onset muscular dystrophy, is autosomal dominant, multisystemic disease with characteristic symptoms including myotonia, heart defects, cataracts and testicular atrophy. DM1 disease is being successfully modelled in Drosophila allowing to identify and validate new pathogenic mechanisms and potential therapeutic strategies. Here we provide an overview of insights gained from fruit fly DM1 models, either: (i) fundamental with particular focus on newly identified gene deregulations and their link with DM1 symptoms; or (ii) applied via genetic modifiers and drug screens to identify promising therapeutic targets.
Related Concept Videos
SN1 Reaction: Mechanism
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
Titrimetric Methods: Types and Commonly Used Strategies
The Quantum-Mechanical Model of an Atom
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism
Satellite Stem Cells and Muscular Dystrophy
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism

